Neoadjuvant and Adjuvant Treatment of Rectal Cancer: Select Publications

Joseph M, Benson AB 3rd. Current issues in rectal cancer chemotherapy. Cancer J 2007;13(3):198-
203. Abstract

Kim T. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer
to define the optimal sequence of chemotherapy and radiotherapy: A final report. Proc ASCO
2007;Abstract 4050.

Kuo LJ et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after
preoperative chemoradiation therapy? Ann Surg Oncol 2007 Jun 6;[Epub ahead of print]. Abstract

Lay GC et al. Phase II study of preoperative irradiation and chemotherapy with capecitabine
in patients with locally advanced rectal carcinoma. J Exp Clin Cancer Res 2007;26(1):61-70.
Abstract

Machiels JP et al. Phase I/II study of preoperative cetuximab, capecitabine, and external beam
radiotherapy in patients with rectal cancer. Ann Oncol 2007;18:738-44. Abstract

McMullen KP, Blackstock AW. Chemoradiation with novel agents for rectal cancer. Clin Colorectal
Cancer 2002;2(1):24-30. Abstract

Meyers MO. Ratio of metastatic to examined lymph nodes is a powerful predictor of overall
survival in rectal cancer: An analysis of Intergroup 0114. Proc ASCO 2007;Abstract 4006.

Vuong T et al. High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients
with resectable rectal cancer. Clin Oncol (R Coll Radiol) 2007 Aug 20;[Epub ahead of print].
Abstract

Willett C. Phase I/II study of neoadjuvant bevacizumab with radiation therapy and 5-
fluorouracil in patients with rectal cancer: Initial results. Proc ASCO 2007;Abstract 4041.

Willett CG et al. Combined vascular endothelial growth factor-targeted therapy and radiotherapy
for rectal cancer: Theory and clinical practice. Semin Oncol 2006;33(5 Suppl 10):S35-
40. Abstract

Willett CG et al. Prognostic factors in stage T3N0 rectal cancer: Do all patients require
postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999;42(2):167-73.
Abstract

Zhu AX, Willett CG. Combined modality treatment for rectal cancer. Semin Oncol
2005;32(1):103-12. Abstract

Terms of Use and General Disclaimer
Copyright © 2007 Research To Practice. All Rights Reserved